Immucor's Galileo syphilis and CMV (cytomegalovirus) tests:
This article was originally published in Clinica
Immucor has received US FDA 510(k) market clearance to run its assays for syphilis (Capture-S) and cytomegalovirus (CMV) on its Galileo analyser, a fully-automated, walk-away instrument for use in hospital blood bank transfusion laboratories, donor centres and reference laboratories. "We expect this test menu expansion will result in increased penetration of the donor centre market with the Galileo," said Gioacchino De Chirico, president of the Norcross, Georgia firm.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.